Literature DB >> 24975516

Promising future for the transgenic rat in transplantation research.

B M Doorschodt1, A Teubner1, E Kobayashi2, R H Tolba3.   

Abstract

The rat is the most widely used animal species in surgical research and offers distinct advantages over the mouse in transplantation models due to its size and close genetic similarity to humans. Sequencing of the rat genome and successful application of transgenic technologies which had only been available for mice have since led to a resurgence of the use of rat models. Transplantation provides the possibility to deliver transgenes through a variety of routes which can potentially offer treatment modalities for post-transplant dysfunction and rejection. Moreover, the use of genetically encoded fluorescent light probes has enabled in vivo visualization of organs and tissue in living animals. In recent years, generation of gene knockout rats via the zinc-finger nuclease (ZFN) and transcription activator-like effector nuclease (TALEN) technologies has offered alternatives to the sophisticated embryonic stem cell based gene-targeting. In this review, we aim to provide an overview of transplantation studies involving transgenic techniques using rat models and recent advances in methods to modify the rat genome. Through novel gene modification techniques, precise, complete and conditional knockout and knockin rat models have become available which can provide promising new treatment options and opportunities for studying human transplant-related pathophysiology.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24975516     DOI: 10.1016/j.trre.2014.05.002

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  7 in total

1.  Phenotypic characterization of a novel HO-1 depletion model in the rat.

Authors:  Vassilios Atsaves; Maria G Detsika; Elpida Poulaki; Hara Gakiopoulou; Elias A Lianos
Journal:  Transgenic Res       Date:  2016-10-24       Impact factor: 2.788

Review 2.  Cell Therapy for Liver Disease Using Bioimaging Rats.

Authors:  Junko Haga; Shin Enosawa; Eiji Kobayashi
Journal:  Cell Med       Date:  2016-10-21

3.  Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2021 Abstracts.

Authors: 
Journal:  Can Liver J       Date:  2021-04-29

4.  Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC), the Canadian Association of Hepatology Nurses (CAHN), and the Canadian NASH Network 2022 Abstracts.

Authors: 
Journal:  Can Liver J       Date:  2022-05-09

5.  Development of in-vitro maturation protocol for rat oocytes; under simple culture vs co-culture with cumulus cell monolayer and its developmental potential via Parthenogenetic/artificial activation.

Authors:  Muhammad Joan Ailia; Yun-Kyong Jin; Hee-Kyoung Kim; Goo Jang
Journal:  BMC Vet Res       Date:  2021-01-22       Impact factor: 2.741

6.  HO-1/BMMSC perfusion using a normothermic machine perfusion system reduces the acute rejection of DCD liver transplantation by regulating NKT cell co-inhibitory receptors in rats.

Authors:  Huan Cao; Longlong Wu; Xuan Tian; Weiping Zheng; Mengshu Yuan; Xiang Li; Xiaorong Tian; Yuxin Wang; Hongli Song; Zhongyang Shen
Journal:  Stem Cell Res Ther       Date:  2021-11-24       Impact factor: 6.832

Review 7.  Renal disease pathophysiology and treatment: contributions from the rat.

Authors:  Linda J Mullins; Bryan R Conway; Robert I Menzies; Laura Denby; John J Mullins
Journal:  Dis Model Mech       Date:  2016-12-01       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.